Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows an updated operating-status notice, new future dates, and a new revision/version (v3.2.0), while removing several past dates and the previous revision (v3.1.0), indicating an updated status and timeline information.
    Difference
    1%
    Check dated 2025-10-07T23:21:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Incremental version update: replacing the old revision tag v3.0.2 with a new v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-30T02:44:11.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Significant content removal: core topics on drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) have been deleted, substantially changing the page's scope.
    Difference
    0.1%
    Check dated 2025-09-22T23:39:11.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; no substantive content changes detected; a Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-15T19:26:36.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-08T15:04:26.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, particularly in various countries, while also removing outdated location references. Additionally, there are updates to the resources related to genetic and rare diseases, specifically concerning acute myeloid leukemia.
    Difference
    9%
    Check dated 2025-09-01T09:34:49.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.